Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer

International Journal of Gynecological Cancer

Volumn 22, Issue 4, 2012, Pages 531-538

  Akita, Kaoru ^a   Yoshida, Shuhei ^a   Ikehara, Yuzuru ^b   Shirakawa, Sayumi ^b   Toda, Munetoyo ^a   Inoue, Mizue ^a   Kitawaki, Jo ^c   Nakanishi, Hayao ^d   Narimatsu, Hisashi ^b   Nakada, Hiroshi ^a  

^a KYOTO SANGYO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

ELISA; Endometriosis; MUC16; Ovarian cancer; Sialyl Tn antigen

Indexed keywords

ANTIGEN; CA 125 ANTIGEN; SIALYL LE ANTIGEN; SIALYL TN ANTIGEN; TN ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER TISSUE; CARCINOMA CELL; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL FILTRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; OVARY CARCINOMA; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ASCITIC FLUID; BLOTTING, WESTERN; CA-125 ANTIGEN; CULTURE MEDIA, CONDITIONED; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OLIGOSACCHARIDES; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84863692192     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182473292     Document Type: Article

References (30)

1. Bast RC Jr, Feeney M, Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68:1331-1337.
2. Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem. 2001;276:27371-27375.
3. O'Brien TJ, Beard JB, Underwood LJ et al. The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumour Biol. 2001;22:348-366.
4. Kui Wong N, Easton RL, Panico M, et al. Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. J Biol Chem. 2003;278:28619-28634.
5. Seelenmeyer C, Wegehingel S, Lechner J, et al. The cancer antigen CA125 represents a novel counter receptor for galectin-1. J Cell Sci. 2003;116:1305-1318.
6. Gubbels JA, Belisle J, Onda M, et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol Cancer. 2006;5:50.
7. Argueso P, Guzman-Aranguez A, Mantelli F, et al. Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier. J Biol Chem. 2009;284:23037-23045.
8. Belisle JA, Horibata S, Jennifer GA, et al. Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes. Mol Cancer. 2010;9:118.
9. Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 2010;29:2893-2904.
10. Bast RC Jr, Klug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309:883-887.
11. Klug TL, Bast RC Jr, Niloff JM, et al. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res. 1984;44:1048-1053.
12. Vergote IB, Onsrud M, Bormer OP, et al. CA125 in peritoneal fluid of ovarian cancer patients. Gynecol Oncol. 1992;44:161-165.
13. Bast RC Jr, Xu FJ, Yu YH, et al. CA 125: the past and the future. Int J Biol Markers. 1998;13:179-187.
14. Meden H, Fattahi-Meibodi A. CA 125 in benign gynecological conditions. Int J Biol Markers. 1998;13:231-237.
15. Kobayashi H, Terao T, Kawashima Y. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer. J Clin Oncol. 1991;9:983-987.
16. Kobayashi H, Terao T, Kawashima Y. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J Clin Oncol. 1992;10:95-101.
17. Matsuda A, Kuno A, Kawamoto T, et al. Wisteria f loribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma. Hepatology. 2010;52:174-182.
18. Kuno A, Ikehara Y, Tanaka Y, et al. Multilectin assay for detecting fibrosis-specific glyco-alteration by means of lectin microarray. Clin Chem. 2011;57:48-56.
19. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67:817-821.
20. Nakada H, Inoue M, Numata Y, et al. Cancer-associated glycoproteins defined by a monoclonal antibody, MLS 128, recognizing the Tn antigen. Biochem Biophys Res Commun. 1992;187:217-224.
21. Tanaka N, Nakada H, Inoue M, et al. Binding characteristics of an anti-Siaalpha2-6GalNAcalpha-Ser/Thr (sialyl Tn) monoclonal antibody (MLS 132). Eur J Biochem. 1999;263:27-32.
22. Kitagawa H, Nakada H, Numata Y, et al. A monoclonal antibody that recognizes sialyl-Lea oligosaccharide, but is distinct from NS 19-9 as to epitope recognition. J Biochem. 1988;104:817-821.
23. Toda M, Hisano R, Yurugi H, et al. Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells. Biochem J. 2009;417:673-683.
24. Ohno S, Ohno Y, Nakada H, et al. Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis. Anticancer Res. 2006;26:4047-4053.
25. Inoue M, Fujita M, Nakazawa A, et al. Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors. Obstet Gynecol. 1992;79:434-440.
26. Davidson B, Gotlieb WH, Ben-Baruch G, et al. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastasesVa clinicopathologic study. Gynecol Oncol. 2000;77:35-43.
27. Ju T, Lanneau GS, Gautam T, et al. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res. 2008;68:1636-1646.
28. Ikehara Y, Kojima N, Kurosawa N, et al. Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2, 6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. Glycobiology. 1999;9:1213-1224.
29. Chauhan SC, Singh AP, Ruiz F, et al. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol. 2006;19:1386-1394.
30. Sekine H, Hayes DF, Ohno T, et al. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma. J Clin Oncol. 1985;3:1355-1363.